The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020

被引:223
作者
Oliver, Sara E. [1 ]
Gargano, Julia W. [1 ]
Marin, Mona [1 ]
Wallace, Megan [1 ,2 ]
Curran, Kathryn G. [1 ]
Chamberland, Mary [1 ,3 ]
McClung, Nancy [1 ]
Campos-Outcalt, Doug [4 ]
Morgan, Rebecca L. [5 ]
Mbaeyi, Sarah [1 ]
Romero, Jose R. [6 ]
Talbot, H. Keipp [7 ]
Lee, Grace M. [8 ]
Bell, Beth P. [9 ]
Dooling, Kathleen [1 ]
机构
[1] CDC, COVID 9 Response Team, Atlanta, GA 30333 USA
[2] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA
[3] Gen Dynam Informat Technol, Falls Church, VA USA
[4] Univ Arizona, Coll Med, Phoenix, AZ USA
[5] Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[6] Arkansas Dept Hlth, Little Rock, AR 72205 USA
[7] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[8] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[9] Univ Washington, Seattle, WA 98195 USA
来源
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2021年 / 69卷 / 51-52期
关键词
D O I
10.15585/mmwr.mm695152e1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:1653 / 1656
页数:4
相关论文
共 8 条
[1]  
Advisory Committee on Immunization Practices, 2020, COVID 19 ACIP VACC R
[2]  
Advisory Committee on Immunization Practices, 2020, ACIP M INF
[3]  
[Anonymous], 2020, ADV COMM IMM PRACT A
[4]  
[Anonymous], 2020, VACC REL BIOL PROD A
[5]  
Food and Drug Administration, 2020, PFIZ COVID 19 VACC E
[6]  
Gazette S, 2020, BAHRAIN APPROVES EME
[7]  
McClung N, 2020, MMWR-MORBID MORTAL W, V69, P1782, DOI 10.15585/mmwr.mm6947e3
[8]  
Vaccines and Related Biological Products Advisory Committee, 2020, VACC REL BIOL PROD A